{"id":"W3155566811","doi":"10.1016/j.arrct.2021.100123","title":"Phase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré Syndrome","year":2021,"lang":"en","type":"article","venue":"Archives of Rehabilitation Research and Clinical Translation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Food and Drug Administration; U.S. Food and Drug Administration","keywords":"Medicine; Physical therapy; Randomized controlled trial; Placebo; Physical medicine and rehabilitation; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002294756,0.00008024616,0.0005141411,0.0001603081,0.00004822549,0.00001089522,0.00005482103,0.00005620213,0.00005472836],"category_scores_gemma":[0.01490014,0.00005296377,0.0002559428,0.0003220698,0.001172518,0.0000611166,0.00001717418,0.0003233257,7.809999e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000451906,"about_ca_system_score_gemma":0.0001147445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004594809,"about_ca_topic_score_gemma":0.00005772995,"domain_scores_codex":[0.9962856,0.002043402,0.0008603737,0.0002528713,0.000401746,0.0001560177],"domain_scores_gemma":[0.9609519,0.03844513,0.0000945631,0.0002689437,0.0001504279,0.00008905217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9171425,0.003312957,0.003504775,0.0001967395,0.00006485652,0.00001496982,0.0009083298,0.00003777726,0.002144296,0.003201667,0.00007797837,0.0693932],"study_design_scores_gemma":[0.9437705,0.01431715,0.02119443,0.0003252821,0.00003481502,0.000002982427,0.0006748391,0.007067326,0.0002383144,0.01172967,0.000572234,0.00007248108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870371,0.0002358566,0.0001709487,0.01056667,0.00004926937,0.00139492,0.00001363527,0.000005813207,0.0005257651],"genre_scores_gemma":[0.996511,0.0009165176,0.0023021,0.00009255557,0.00002042208,0.00004304403,0.0000246752,0.000007943606,0.00008176772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06932072,"threshold_uncertainty_score":0.9933978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1987072062623221,"score_gpt":0.4523032135257067,"score_spread":0.2535960072633847,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}